Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shujiele Granules
- Development stage
- Unknown
- Lead developer
- Chengdu University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shujiele Granules (舒解乐颗粒) is a Traditional Chinese Medicine (TCM) formulation developed by the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine for the treatment of depression. It is specifically indicated for patients diagnosed with the TCM syndrome of liver qi stagnation and spleen deficiency. The preparation is composed of multiple herbal extracts, including Bupleurum chinense and Paeonia lactiflora, which are traditionally used to soothe the liver, relieve depression, and harmonize the spleen. Pharmacological research indicates that Shujiele Granules may exert its antidepressant effects by modulating the neuroendocrine-immune system, specifically by regulating the levels of monoamine neurotransmitters such as serotonin (5-HT) and norepinephrine (NE) in the central nervous system, and potentially balancing the hypothalamic-pituitary-adrenal (HPA) axis. It has been evaluated in Phase 2 clinical trials in China, showing potential efficacy in improving depressive symptoms with a safety profile that is generally superior to some conventional chemical antidepressants.
- Brand names
- Shujiele
- Other names
- Shujiele Keli舒解乐颗粒
Beyond the preview
Go deeper on Shujiele Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shujiele Granules.